Sign in to view content

Diabetic Retinopathy and the MyVisionTrack App Study (DRAMA)

Samuel K. Steven Houston, MD, FASRS

Video
Published 2017

Related

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more